In addition, the proportion of MIC results other than <0.125 μg/mL among all MIC results obtained for Candida strains from the study group was greater in the group of patients receiving MTX at a dose of at least 20 mg/week than in patients receiving MTX at lower doses (7/28 (25.00%) and 2/21 (09.52%) respectively), but this relationship did not reach statistical significance (RR = 2.63, 95% CI: 0.61–11.31, p = 0.20).
← all excerpts
Does Systemic Methotrexate Therapy Induce Azole Resistance among Endogenous <i>Candida</i> Strains?
1
0.2000
0.2000